3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
3
CNS
3
Other hematologic neoplasm
2
Gastrointestinal
2
Endocrine
2
Dermatologic
2
Sarcoma
1
Plasma cell
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Conditions
Lymphoma
539
Precursor Cell Lymphoblastic Leukemia-Lymphoma
499
Lymphoma, Non-Hodgkin
435
Lymphoma, Follicular
403
Leukemia, Lymphocytic, Chronic, B-Cell
388
Lymphoma, Large B-Cell, Diffuse
385
Lymphoma, B-Cell
246
Lymphoma, Mantle-Cell
222
Hodgkin Disease
207
Recurrence
204
Leukemia, Myeloid, Acute
197
Leukemia
191
Multiple Myeloma
184
Burkitt Lymphoma
181
Lymphoma, B-Cell, Marginal Zone
170
Neoplasms
151
Myelodysplastic Syndromes
132
Hematologic Neoplasms
115
Waldenstrom Macroglobulinemia
103
Lymphoma, T-Cell, Peripheral
85
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
81
Lymphoma, T-Cell
81
Lymphoma, T-Cell, Cutaneous
66
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
62
Mycosis Fungoides
57
Leukemia, Biphenotypic, Acute
54
Breast Neoplasms
54
Myeloproliferative Disorders
50
Leukemia, B-Cell
50
Lymphoproliferative Disorders
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rare Diseases
×
Lymphoid
×
1 year
×
Clear all
NCT06714370
2026-05-20
REVEAL
Ono Pharmaceutical Co., Ltd.
Completed
24 enrolled